Tumor Hyperinsulinism (Tumor HI)
1 clinical trials · Condition
◉ Watch Tumor Hyperinsulinism (Tumor HI)
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism (NCT06881992) | Rezolute | 2025-04-16 |
Track Tumor Hyperinsulinism (Tumor HI) automatically
Every clearance here is in the API, with alerts when new ones post.